ArticleScientific reports2025
Development, characterization and biological studies of Mn-doped ZnO/Ti biomaterials for regenerative medicine.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Mn Doping Enhances the Antibacterial, Antibiofilm and Anti-Virulence Activity of ZnO Nanoparticles.Nanomaterials (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Bone disease diseases massively affect the world population, with more than two million of surgeries performed worldwide every year. Bone has limited capability to repair very large defects and the use of engineered biomaterials isa mandatory but some clinical issues are observed like rejection and possible infections. Therefore, the development of new biomaterials promoting bone tissue repair and prevent post-surgery infections represents one of the main challenge in regenerative medicine. Titanium is the most used material for implants but it not free from infections. Therefore the modification of Ti surface could represent a valuable strategy to improve both antibacterial and osteo-inductive properties. In this work, we developed a Mn-doped ZnO/Ti biomaterial and evaluated its ability to prevent infections, preserving the osteo-integration. Results indicate that the biomaterial is very effective in antibacterial activity with a bacterial reduction of more than 80% in the case of Staphylococcus aureus, and of 44.4% and 53.6% in the case of Pseudomonas aeruginosa, while maintaining both biocompatibility and the ability to promote osteogenic differentiation, as confirmed by upregulation of key genes (ALP, IBSP, SPARC) in human osteoblasts. This paves the way for a new class of biomaterials for regenerative medicine applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.